Data underlying the Research on Anti-CD79b/CD3 Bispecific Antibody Enhances Anti-tumor Effects of CAR19-T Cells in B-cell Lymphoma

doi:10.4121/19416764.v1
The doi above is for this specific version of this dataset, which is currently the latest. Newer versions may be published in the future. For a link that will always point to the latest version, please use
doi: 10.4121/19416764
Datacite citation style:
Zheng Weiwei; Han Zhou; Ping Li; Shi-Guang Ye; Tuersunayi Abudureheman et. al. (2022): Data underlying the Research on Anti-CD79b/CD3 Bispecific Antibody Enhances Anti-tumor Effects of CAR19-T Cells in B-cell Lymphoma. Version 1. 4TU.ResearchData. dataset. https://doi.org/10.4121/19416764.v1
Other citation styles (APA, Harvard, MLA, Vancouver, Chicago, IEEE) available at Datacite
Dataset
This dataset was generated to comfirm that a new constructed anti-CD79b/CD3 bispecific antibody could enhanced T cells or CAR19 T cells cytoxicity to B-cell lymphoma in vitro and in vivo.This is a original research by cell and anminal expriment.Most data was collected by flow cytometric analysis, using flowjo V10 to analyse the original fsc file and Graphpad Prism9 to make a graph; SDS-PAGE and Western blot image were took by Tanon-3500 gel imaging system; And other details can be found in the corresponding article.The type of final data includes images ,docx and pdf.
history
  • 2022-03-25 first online, published, posted
publisher
4TU.ResearchData
format
image docx pdf
organizations
Shanghai Jiao Tong University School of Medicine, Shanghai, China

DATA

files (9)